At the news
? MIXEDIMPACT 6/10 8-K filed Apr 22, 2026 at 16:15 ET
Medpace reported strong Q1 2026 earnings with revenue up 26.5% YoY and EPS of $4.28, beating consensus. However, President Jesse Geiger announced his resignation effective May 31, 2026, creating leadership uncertainty. The stock faces mixed signals from solid financials versus executive transition risk.
- Q1 2026 revenue: $706.6M, up 26.5% YoY
- Q1 2026 EPS: $4.28, beating consensus of $3.74
- President Jesse Geiger to resign May 31, 2026
- CEO August Troendle to reassume President role temporarily
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access